CD200 and neoplasm: However an adverse effect of CD200-CD200R blockade is also possible as CD200 expression increases with progression of squamous cell carcinoma, suggesting that CD200-expressing tumour cells engage and modulate tumour associated myeloid-derived suppressor cells [102, 103].